pemafibrate
Kowa Pharmaceuticals
[]
pemafibrate lowered tg but increased ldl-c leading to an overall *null* apob-effect. resoundingly clear- it s all about apob-lowering for addressing atherogenic lipoprotein-related risk #aha22
Dir of Prev Cardiology @MassGeneralNews | Assoc Prof @harvardmed | Assoc Mem @broadinstitute | Assoc Ed @JAMACardio @ScienceAdvances